VSD-31916-16024
4 vaccinations
7 coded responses
30 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 801 / CO
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QFV-30101-94015
Child or adolescent in my care · Female · 2022-09-07
Timeline
-
2021-03-03
Dose 1 — Moderna
-
2021-03-08
Registered in v-safe
-
2021-03-08
Survey response — days 1–6 daily, dose 1MedDRA: Suppressed lactation, Supraventricular tachycardia — Feeling: GoodFree text: SVT episode about 48 hours after the shot. Also I am lactating mom and had reduced breast milk production for 3 days after shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-09
-
2021-03-10
Survey response — day 7, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: I have had a swollen lymph node in my armpit of the injection arm since the day after the shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Survey response — day 14, dose 1MedDRA: Condition aggravated, Pre-existing disease, Supraventricular tachycardia — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Had another minor episode of SVT.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-24
-
2021-03-31
Dose 2 — Moderna
- 2021-03-31
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Suppressed lactation — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: 25% reduction in breast milk supply (I am lactating)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Oedema peripheral, Suppressed lactation — Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessFree text: Swollen underarm on side where got shot; breast milk reduction by about 10%MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-04
-
2021-04-05
Survey response — days 1–6 daily, dose 2MedDRA: Maternal exposure during breast feeding, Suppressed lactation — Feeling: Good · Site: PainFree text: Still have about 10-20% breast milk reduction.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-09
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-06-30
- 2021-10-01
-
2021-12-03
Dose 3 — Moderna
- 2021-12-17
- 2021-12-22
- 2022-04-02
- 2022-06-03
-
2022-09-24
Dose 4 — Pfizer-BioNTech
-
2022-09-27
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-09-28
- 2022-10-08
-
2022-10-15
Survey response — day 21, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-10-15
Report sent to call center — day 21, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-17
Call successfulReported to VAERS during previous contact from GDIT
-
2022-10-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-24
- 2022-10-29
- 2022-11-05
- 2023-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Moderna | |
| 2 | 2021-03-31 | Moderna | |
| 3 | 2021-12-03 | Moderna | No |
| 4 | 2022-09-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-17 | Successful 2022-10-17 |
Reported to VAERS during previous contact from GDIT |
| 2022-10-15 | Successful 2022-10-17 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): SVT episode about 48 hours after the shot. Also I am lactating mom and had reduced breast milk production for 3 days after shot.
Release 5 — day 7, dose 1
Systemic reaction (other): I have had a swollen lymph node in my armpit of the injection arm since the day after the shot.
Release 5 — day 14, dose 1
Symptoms: Had another minor episode of SVT.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): 25% reduction in breast milk supply (I am lactating)
Systemic reaction (other): Swollen underarm on side where got shot; breast milk reduction by about 10%
Systemic reaction (other): Still have about 10-20% breast milk reduction.
Release 12 — day 21, dose 4
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Supraventricular tachycardia | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Maternal exposure during breast feeding | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | ✓ | ✓ | ✓ |
| SRO | Suppressed lactation | ✓ | ✓ | ✓ |
| SRO | Supraventricular tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release